Alembic Pharma gets USFDA nod for generic high blood pressure treatment drug

Alembic Pharmaceuticals announced that it has secured final approval from the USFDA for its generic amlodipine and atorvastatin tablets, used for treating hypertension. The approval covers multiple strengths of the tablets, therapeutically equivalent to Pharmacia and Upjohn Co LLC's Caduet. With this approval, Alembic now has a cumulative total of 223 ANDA approvals from the USFDA.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/LOfTUnE
via IFTTT